Search | IOVS | ARVO Journals

Showing 1 – 20 of 36

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Longitudinal Changes in Aqueous Humor Cytokines in Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factor Therapy

Joseph R Abraham; Charles C. Wykoff; sruthi arepalli; David M Brown; Leina Lunasco; Ming Hu; Justis P Ehlers

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):276. doi:

ARVO Annual Meeting Abstract June 2020

Association of Aqueous Cytokine Profile and Extracted OCT Features in Diabetic Macular Edema: Assessment of the Anatomic-Biologic Bridge

Nicole Cardwell; Joseph R Abraham; Charles C. Wykoff; Leina Lunasco; David M Brown; sruthi arepalli; Sunil K Srivastava; Thuy k. Le; Sarah Biehl; Carmen Calabrise; Stephanie Kaiser; Duriye Damla Sevgi; Rucha Tadwalkar; Ming Hu; Jamie Reese; Justis P Ehlers

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):40. doi:

ARVO Annual Meeting Abstract June 2020

Visual Acuity Variability: Comparing Discrepancies Between Snellen and ETDRS Measurements Among Subjects Entering Prospective Clinical Trials

Hannah Yu; Peter M Kaiser; Deneva Zamora; Melisa Bocanegra; Cassandra Cone; David M Brown; Srinivas Sadda; Charles Clifton Wykoff

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2652. doi:

ARVO Annual Meeting Abstract June 2020

Correlation of Ultra-widefield Fluorescein Angiographic Features with Intraocular Cytokine Expression in Diabetic Macular Edema: Exploring the Angiographic-Biologic Phenotype

Christopher J. Mugnaini; Joseph R Abraham; Charles C. Wykoff; Leina Lunasco; David M Brown; sruthi arepalli; Sunil K Srivastava; Alison Martin; Katie Gregory; Jamie Reese; Justis P Ehlers

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4867. doi:

ARVO Annual Meeting Abstract June 2020

Analysis of choriocapillaris flow impairment in intermediate age-related macular degeneration as a predictor of progression to exudative choroidal neovascularization

Luísa Salles de Moura Mendonca; Jeffrey S Heier; David S Boyer; David M Brown; Sumit P Shah; A. Yasin Alibhai; Namrata Saroj; Sabin Dang; Nadia K Waheed

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4092. doi:

ARVO Annual Meeting Abstract June 2020

Longitudinal Assessment of Intraocular Cytokine Expression in Retinal Venous Occlusive Disease Following Anti-VEGF Therapy

sruthi arepalli; Charles C. Wykoff; Joseph R Abraham; David M Brown; Leina Lunasco; Jamie Reese; Justis P Ehlers

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3300. doi:

ARVO Annual Meeting Abstract June 2020

Correlation of Intraocular Cytokine Expression with Higher Order OCT Features in Retinal Venous Occlusive Disease

John Gabriel; Joseph R Abraham; Charles Clifton Wykoff; David M Brown; Leina Lunasco; Shruthi Arepalli; Sunil K Srivastava; Margaret O'Connell; Thuy k. Le; Duriye Damla Sevgi; Sarah Biehl; Olivia Rentz; Marin Berlon; Ming Hu; Jamie Reese; Justis P Ehlers

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1330. doi:

ARVO Annual Meeting Abstract July 2019

Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in patients with Diabetic Macular Edema

Mengyuan Fang; wenying fan; Yue Shi; Michael S Ip; Charles Clifton Wykoff; Kang Wang; Khalil Ghasemi Falavarjani; David M Brown; Jano van Hemert; Srinivas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2805. doi:

ARVO Annual Meeting Abstract July 2019

Noncompliance in retinal clinical trials: an analysis of factors that predict loss to follow up in multiple prospective studies

Brenda Zhou; Travis Mitchell; Alexander Michael Rusakevich; David M Brown; Charles Clifton Wykoff

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3960. doi:

ARVO Annual Meeting Abstract July 2019

Detection of choroidal neovascular membranes using OCT Angiography: Learnings from the PROCON Study

Sabin Dang; Nadia K Waheed; David S Boyer; David M Brown; Sumit Shah; Jeffrey S. Heier

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3482. doi:

ARVO Annual Meeting Abstract July 2018

Clinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular DegenerationClinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular Degeneration

Michael J Elman; David M Brown; Peter K Kaiser; Jason S Slakter

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4950. doi:

ARVO Annual Meeting Abstract July 2018

Intravitreal Aflibercept Injection (IAI) for Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study

David M Brown

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1889. doi:

ARVO Annual Meeting Abstract July 2018

Predictability of the 12-week dosing status at Week 48 for patients receiving brolucizumab in HAWK and HARRIER

Pravin U Dugel; Gabriele Elisabeth Lang; Sam Razavi; Andreas Weichselberger; Yuichiro Ogura; David M Brown

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1455. doi:

ARVO Annual Meeting Abstract July 2018

Suprachoroidal Space Alterations after Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients with Diabetic Macular Edema

Shaun Ian Retief Lampen; Rahul N. Khurana; David M Brown; Charles Clifton Wykoff

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1096. doi:

ARVO Annual Meeting Abstract July 2018

Dermatopathologic and Optical Coherence Tomography “Cracked Mud Sign” in Pseudoxanthoma Elasticum.

Ashley E. Brown; Charles Clifton Wykoff; Sylvia Hsu; David M Brown

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1129. doi:

ARVO Annual Meeting Abstract June 2017

Longitudinal Quantification of Retinal Nonperfusion in Eyes with Retinal Vein Occlusion Receiving Ranibizumab With or Without Targeted Peripheral Laser Photocoagulation

William Christopher Ou; David M Brown; Charles Clifton Wykoff

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1534. doi:

ARVO Annual Meeting Abstract June 2017

Impact of baseline retinal nonperfusion on best corrected visual acuity in eyes with central retinal vein occlusion: post hoc analyses of COPERNICUS and GALILEO

David M Brown; Yuichiro Ogura; Francesco Boscia; Frank G Holz; Jean-Francois Korobelnik; Jeffrey Heier; Kay D Rittenhouse; Friedrich Asmus; Christiane Ahlers; Florian Hiemeyer; Chengxing Lu; Robert Vitti; Namrata Saroj; Nicolas Feltgen

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1559. doi:

ARVO Annual Meeting Abstract June 2017

Elevated Choroidal Thickness and Central Serous Chorioretinopathy in the Fellow Eye of Patients with Circumscribed Choroidal Hemangioma

Daniel Gologorsky; Rishabh Jain; David M Brown; Maria Eugene Bretana; Eric Kegley; Michael Singer; Amy C Schefler

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1784. doi:

ARVO Annual Meeting Abstract June 2017

Distribution of Nonperfusion Area on Ultra Widefield Angiography in Eyes with Diabetic Macular Edema: DAVE Study

wenying fan; Kang Wang; Khalil Ghasami Falavarjani; Min Sagong; Akihito Uji; Michael S Ip; Jano van Hemert; Charles Clifton Wykoff; David M Brown; Srinivas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):920. doi:

ARVO Annual Meeting Abstract September 2016

CNV lesion characteristics as a predictor of visual outcome in wet AMD patients receiving combination therapy of intravitreal anti-VEGF therapy and topical Squalamine lactate ophthalmic solution.

David M Brown; Avner Ingerman; Shawn Patrick Shearn; Jason S Slakter

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4419. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Longitudinal Changes in Aqueous Humor Cytokines in Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factor Therapy

Association of Aqueous Cytokine Profile and Extracted OCT Features in Diabetic Macular Edema: Assessment of the Anatomic-Biologic Bridge

Visual Acuity Variability: Comparing Discrepancies Between Snellen and ETDRS Measurements Among Subjects Entering Prospective Clinical Trials

Correlation of Ultra-widefield Fluorescein Angiographic Features with Intraocular Cytokine Expression in Diabetic Macular Edema: Exploring the Angiographic-Biologic Phenotype

Analysis of choriocapillaris flow impairment in intermediate age-related macular degeneration as a predictor of progression to exudative choroidal neovascularization

Longitudinal Assessment of Intraocular Cytokine Expression in Retinal Venous Occlusive Disease Following Anti-VEGF Therapy

Correlation of Intraocular Cytokine Expression with Higher Order OCT Features in Retinal Venous Occlusive Disease

Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in patients with Diabetic Macular Edema

Noncompliance in retinal clinical trials: an analysis of factors that predict loss to follow up in multiple prospective studies

Detection of choroidal neovascular membranes using OCT Angiography: Learnings from the PROCON Study

Intravitreal Aflibercept Injection (IAI) for Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study

Predictability of the 12-week dosing status at Week 48 for patients receiving brolucizumab in HAWK and HARRIER

Suprachoroidal Space Alterations after Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients with Diabetic Macular Edema

Dermatopathologic and Optical Coherence Tomography “Cracked Mud Sign” in Pseudoxanthoma Elasticum.

Longitudinal Quantification of Retinal Nonperfusion in Eyes with Retinal Vein Occlusion Receiving Ranibizumab With or Without Targeted Peripheral Laser Photocoagulation

Impact of baseline retinal nonperfusion on best corrected visual acuity in eyes with central retinal vein occlusion: post hoc analyses of COPERNICUS and GALILEO

Elevated Choroidal Thickness and Central Serous Chorioretinopathy in the Fellow Eye of Patients with Circumscribed Choroidal Hemangioma

Distribution of Nonperfusion Area on Ultra Widefield Angiography in Eyes with Diabetic Macular Edema: DAVE Study

CNV lesion characteristics as a predictor of visual outcome in wet AMD patients receiving combination therapy of intravitreal anti-VEGF therapy and topical Squalamine lactate ophthalmic solution.

To View More...

You must be signed into an individual account to use this feature.